Volpara gets new US customers for cancer software
WELLINGTON: Breast cancer diagnostics company Volpara Health Technologies has announced new US healthcare ... read more
Gain in US prostate cancer sales disappoints Telix investors
MELBOURNE: ASX-listed biotech Telix Pharmaceuticals has reported a near 40 per cent sales ... read more
Sonic and Proteomics edge closer to major medical breakthrough
MELBOURNE: Australian life sciences company Proteomics has extended its agreement with pathology giant ... read more
Shares in Recce Pharmaceuticals lift after Australian patent granted
PERTH: Shares in Perth-founded Recce Pharmaceuticals have lifted after the company announced it ... read more
